Channels and their logos
Moderna’s mRNA vaccine reaches its final phase. Here's how it works.
Moderna’s mRNA vaccine reaches its final phase. Here's how it works. The biotech firm's leading candidate has just entered phase three clinical trials in the U.S. Find out why this vaccine technology is promising—but not without its skeptics. 7 Minute Read By Nsikan Akpan PUBLISHED July 27, 2020 A promising coronavirus vaccine candidate hit another milestone this week, when Moderna Therapeutics began phase three of clinical trials. The move signals the biotech company and the National Institutes of Health, which are collaborating on the trial, are one step away from bringing the drug to the public and commercial markets. After nearly seven months of global deaths and economic shutdowns wrought by the COVID-19 pandemic, people ...
Комментарии
Отправить комментарий